Cardiac ablation, a procedure designed to address heart rhythm disorders by disrupting abnormal electrical signals, is not without its set of potential complications. Among these, bleeding or infection at the catheter insertion site poses a common risk. Furthermore, there is a potential for damage to nearby blood vessels or nerves, heightening the possibility of complications such as blood clots or inadvertent injury to surrounding organs. In some instances, cardiac ablation might lead to the unintended consequence of creating new heart rhythm issues or exacerbating existing ones. While these complications are relatively common, more severe but rare outcomes may include damage to the heart's electrical system, necessitating the use of a pacemaker or implantable cardioverter-defibrillator (ICD). As with any medical intervention, patients should engage in thorough discussions with their healthcare providers to weigh the benefits against the potential risks and make informed decisions regarding cardiac ablation.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt